We recognize the critical link between obesity, cardiovascular disease, and other comorbidities, says Dharmesh Patel, MD, FACC, cardiologist in north Mississippi and president of the Partnership to Advance Cardiovascular Health, in a release
The specific answer to the question regarding the frequency with which any given patient would benefit from repeat Meibomian gland probing is multifactorial and unique to each individual
It can be challenging to distinguish which medicine is causing side effects when two meds are started at once. Her recommendation for understanding each drugs impact
GLP-1s have been used for almost two decades in the treatment of Type 2 diabetes
Because it has not yet received MHRA or EMA marketing authorisation, its full safety profile particularly beyond 48 weeks is still being established
The patient-facing output is a labeled vial with a documented draw volume per dose